Literature DB >> 17713687

Current clinical research environment: focus on psychiatry.

Sonia Mansoldo Dainesi1, Helio Elkis.   

Abstract

The introduction of international guidelines on Good Clinical Practices (GCP) in 1996, immediately followed by the publication of Resolution CNS 196/96 in Brazil, created a great opportunity for Brazilian research centers to participate in international trials. Such studies must be strictly monitored in order to assure compliance with the regulations, as well as with the standards of patient safety. Clear agreement among the investigator, the sponsor and the institution carrying out the study must be previously defined in order to avoid any conflicts of interest during or after the study. Operational aspects, such as the time needed to gain regulatory approval of the study design, strategies for patient recruitment/retention and appropriate logistics, are also important. In 2005, the Brazilian National Clinical Research Network was established, bringing together a number of research centers in teaching hospitals. The objective was to subsidize public clinical research with state-of-the-art practices and appropriate technical/scientific training programs. The development of research protocols that prioritize public health care needs in Brazil is other fundamental goal of this network. This article addresses general aspects of clinical research, as well as some specific issues in psychiatry. Improving the health and quality of life of the global population is certainly the major objective of all of the work done in this area.

Entities:  

Mesh:

Year:  2007        PMID: 17713687     DOI: 10.1590/s1516-44462006005000049

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  1 in total

1.  Randomised trials relevant to mental health conducted in low and middle-income countries: a survey.

Authors:  Rebecca J Syed Sheriff; Clive E Adams; Prathap Tharyan; Mahesh Jayaram; Lelia Duley
Journal:  BMC Psychiatry       Date:  2008-08-14       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.